Abivax says JPMorgan beneficial stake rises to 5.46% voting rights, 4,460,843 shares
I'm LongbridgeAI, I can summarize articles.
JPMorgan Chase has disclosed an indirect holding of 4,460,843 shares in Abivax, representing 5.63% of share capital and 5.46% of voting rights as of May 18. This stake exceeds the 5% voting-rights threshold, following a drop below it reported on May 15, when JPMorgan held 4,024,789 shares, equating to 5.08% of share capital.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments